Cronos Group Inc. is projected to rise to $3.69 by 2027, a +30% move from its current price of $2.83. CRON is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $2.79 | $2.83 | $2.87 | +0.04% |
| Aug 3 | $2.78 | $2.83 | $2.89 | +0.08% |
| Aug 4 | $2.77 | $2.83 | $2.90 | +0.12% |
| Aug 5 | $2.76 | $2.83 | $2.91 | +0.16% |
| Aug 6 | $2.75 | $2.84 | $2.92 | +0.20% |
| Aug 7 | $2.75 | $2.84 | $2.93 | +0.24% |
| Aug 8 | $2.74 | $2.84 | $2.94 | +0.29% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.74 | $2.84 | $2.94 | +0.29% |
| Week 2 | $2.71 | $2.85 | $2.99 | +0.57% |
| Week 3 | $2.69 | $2.85 | $3.03 | +0.86% |
| Week 4 | $2.67 | $2.86 | $3.07 | +1.15% |
| Week 5 | $2.66 | $2.87 | $3.10 | +1.44% |
| Week 6 | $2.64 | $2.88 | $3.13 | +1.72% |
| Week 7 | $2.63 | $2.89 | $3.16 | +2.01% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cronos Group Inc. is a cannabinoid company that engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names.
The company is headquartered in Stayner, Canada.
It is categorized in Healthcare.
Cronos Group Inc. trades with the CRON ticker. Its current price is $2.78 and the market cap is $1.04B. Its rank is 2425.
The forecast shows a path of upside beginning in 2026 with the 2026 average price at $2.78 and neutral sentiment, then moving higher in following years as the averages rise to successive targets through 2030.
By 2040 the average price is forecast at $13.55 with bullish sentiment and a strong rise in ROI, and by 2050 the average is $26.71 with a very large upside of 860.9% projected.
A major floor 13.8% below — a decisive break under it would weaken the trend.
The nearest floor, 6.4% below — buyers have tended to step in here.
Price is pressing into resistance (2.1% away) — a breakout level to watch.
A major ceiling 7.1% above — clearing it would confirm fresh momentum.
Key CRON support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CRON market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.86 | Sell | $2.85 | Sell |
| MA 10 | $2.82 | Buy | $2.83 | Buy |
| MA 20 | $2.79 | Buy | $2.80 | Buy |
| MA 50 | $2.76 | Buy | $2.76 | Buy |
| MA 100 | $2.68 | Buy | $2.71 | Buy |
| MA 200 | $2.64 | Buy | $2.62 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.61 | Neutral |
| Stoch RSI (14) | 45.43 | Neutral |
| CCI (20) | 70.22 | Neutral |
| Williams %R (14) | -40.00 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 3.28 | Buy |
| Bollinger %B (20,2) | 0.72 | Neutral |
| Stochastic %K (14) | 60.00 | Neutral |
| TRIX (15) | 0.11 | Buy |
| Awesome (5,34) | 0.09 | Buy |
| Ultimate (7,14,28) | 59.93 | Neutral |
| Momentum (10) | 0.04 | Buy |
| Aroon Osc (25) | 96.00 | Buy |
| Hull MA (9) | 2.88 | Sell |
| ADX (14) | 10.81 | Neutral |
| ATR (14) | 0.03 | Info |
Technical sentiment is BULLISH. The RSI14 is 50, with the 50-day simple moving average at $2.74 and the 200-day simple moving average at $2.64.
Support is at $2.60 and resistance at $2.86, with a 30-day price range of $2.55 to $3.03.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.39 | $2.83 | $3.75 | 0% | Neutral | |
| $3.03 | $3.69 | $4.70 | +30% | Bullish | |
| $3.58 | $4.44 | $5.82 | +57% | Bullish | |
| $4.05 | $5.11 | $6.84 | +81% | Bullish | |
| $4.13 | $5.28 | $7.19 | +87% | Bullish | |
| $4.50 | $5.83 | $8.06 | +106% | Bullish | |
| $4.91 | $6.43 | $9.03 | +127% | Bullish | |
| $5.25 | $6.94 | $9.87 | +145% | Bullish | |
| $6.33 | $8.46 | $12.18 | +199% | Bullish | |
| $7.09 | $9.57 | $13.92 | +238% | Bullish | |
| $9.78 | $13.77 | $21.00 | +387% | Bullish | |
| $18.11 | $27.34 | $44.68 | +866% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.39 | $2.83 | $3.46 | +0.00% |
| September 2026 | $2.54 | $2.97 | $3.57 | +5.10% |
| October 2026 | $2.49 | $2.94 | $3.55 | -1.26% |
| November 2026 | $2.49 | $2.95 | $3.58 | +0.43% |
| December 2026 | $2.58 | $3.07 | $3.75 | +3.94% |
Click any year to see its month-by-month CRON forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, CRON is projected to trade between $2.39 and $3.75, averaging $2.83 — a potential gain of 0% from today's $2.83. A consolidation phase looks the most probable path here.
Cronos Group Inc.'s 2027 outlook centres on $3.69, within a $3.03 to $4.70 range. That is up +30% on the projected 2026 average. That marks a +30% change versus current levels. Momentum favours further upside here.
By 2028, CRON could reach as high as $5.82, with a base case around $4.44 and support toward $3.58 — roughly +57% from $2.83. Buyers look set to stay in control over this stretch.
Expect CRON to range from $4.05 to $6.84 through 2029. The $5.11 average target implies a +81% move from current prices. That is up +15% on the projected 2028 average. Momentum favours further upside here.
The CRON price prediction for 2030 points to an average of $5.28 (low $4.13, high $7.19) — a potential gain of +87% on today's $2.83. Buyers look set to stay in control over this stretch.
In 2031, CRON is projected to trade between $4.50 and $8.06, averaging $5.83 — a potential gain of +106% from today's $2.83. That is up +10% on the projected 2030 average. Momentum favours further upside here.
Cronos Group Inc.'s 2032 outlook centres on $6.43, within a $4.91 to $9.03 range. That is up +10% on the projected 2031 average. That marks a +127% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, CRON could reach as high as $9.87, with a base case around $6.94 and support toward $5.25 — roughly +145% from $2.83. Momentum favours further upside here.
Expect CRON to range from $6.33 to $12.18 through 2034. The $8.46 average target implies a +199% move from current prices. That is up +22% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The CRON price prediction for 2035 points to an average of $9.57 (low $7.09, high $13.92) — a potential gain of +238% on today's $2.83. Momentum favours further upside here.
In 2040, CRON is projected to trade between $9.78 and $21.00, averaging $13.77 — a potential gain of +387% from today's $2.83. That is up +44% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Cronos Group Inc.'s 2050 outlook centres on $27.34, within a $18.11 to $44.68 range. That is up +99% on the projected 2040 average. That marks a +866% change versus current levels. Momentum favours further upside here.
Investing $1,000 in CRON today (≈ 353.35689 CRON) could be worth
$9,659.8
+$8,659.8 (+866%) by 2050 · US Dollar
Based on the average projected CRON price of $27.34 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CRONwould be worth at today's price.
$1,000 invested in CRON on Jul 31, 2025 (≈ 505.0505 CRON) would be worth
$1,429.29
+$429.29 (+42.9%) today · 1.43× · US Dollar
Based on a CRON entry price of $1.98 vs. today's $2.83.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.81 | $1,007.12 | +0.7% |
| 1 month ago | $2.86 | $989.51 | -1.0% |
| 3 months ago | $2.64 | $1,071.97 | +7.2% |
| 6 months ago | $2.51 | $1,127.49 | +12.7% |
| 1 year ago | $1.98 | $1,429.29 | +42.9% |
| All time (5.0y) ago | $7.33 | $386.08 | -61.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CRON forecast.
Our base-case forecast reaches $5.70 around 2031.
Implied market cap at $5.70: $2.13B
The multi-year forecast shows bullish sentiment from 2027 onward, with rising averages: 2026 avg $2.78 (neutral), 2027 avg $3.63, 2028 avg $4.37, 2029 avg $5.03, and 2030 avg $5.15 (all bullish). The corresponding ROIs rise from 30.4% in 2027 to 85.3% in 2030.
Continuing the track, 2031 avg $5.73 (ROI 106.3%), 2032 avg $6.32 (ROI 127.5%), 2033 avg $6.74 (ROI 142.5%), 2034 avg $8.34 (ROI 200.1%), and 2035 avg $9.42 (ROI 238.9%), all with bullish sentiment.
In 2040, the forecast shows avg $13.55 (ROI 387.4%) and bullish sentiment, and by 2050, avg $26.71 (ROI 860.9%) with bullish sentiment. These are estimates and not guarantees of future results.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $5.15, with a min of $4.03 and a max of $7.02, and an ROI of 85.3% with bullish sentiment.
The forecast features bullish sentiment in 2027, 2028, 2029, 2030, 2031, 2032, 2033, 2034, 2035 and beyond, with increasing averages and ROIs up to 860.9% by 2050. These are estimates, not guarantees.
Yes. The forecast shows a max of $20.66 in 2040 and a max of $43.67 in 2050, indicating upside above $10 in the long term.
Current price is $2.78 and market cap is $1.04B; its rank is 2425.
The 30-day range is $2.55 to $3.03, RSI14 is 50, SMA50 is $2.74, SMA200 is $2.64, with support at $2.60 and resistance at $2.86, and sentiment is BULLISH.
Cronos Group Inc. Community Discussion
0Share your Cronos Group Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.